Lisa Beck

Deans Professor

University of Rochester

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Lisa Beck is the Deans Professor at the University of Rochester, located in the United States. Her research primarily focuses on atopic dermatitis and inflammatory skin diseases, reflected in her recent publications concerning the efficacy of various treatments and the role of immune mechanisms in these conditions. She has contributed significantly to the understanding of therapeutic interventions for pediatric patients and the impact of skin barrier function in dermatological health.

Articles (17)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (14)

Nicolette W. de Jong

NETHERLANDS

View details

Kate Grimshaw

Manchester Metropolitan University

UNITED KINGDOM

View details

Kirsi Jarvinen

Associate Professor, Chief

University of Rochester Medical Center

UNITED STATES

View details

Mette Søndergaard Deleuran

Aarhus University

DENMARK

View details

Matthew Brewer

Research Assistant Professor

University of Rochester

UNITED STATES

View details

E. L. Simpson

UNITED STATES

View details

Masayuki Amagai

JAPAN

View details

Michael Makris

National and Kapodistrian University of Athens

GREECE

View details

Anna De Benedetto

UNITED STATES

View details

Kenji Kabashima

JAPAN

View details

S.R. Gill

University of Rochester School of Medicine and Dentistry

UNITED STATES

View details

Juilee Thakar

Associate Professor

University of Rochester

UNITED STATES

View details

Bruce Strober

Clinical Professor

Yale University School of Medicine

UNITED STATES

View details

H. Mark Kenney

University of Rochester Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lisa Beck

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitis

The vIGA‐AD scale for atopic dermatitis: Uptake in the past 5 years and position of the International Eczema Council

The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trials

Atopic dermatitis and IgE-mediated food allergy

Improved patient‐ and caregiver‐reported outcomes distinguish tacrolimus 0.03% from crisaborole in children with atopic dermatitis

IgE Sensitization Drives the Atopic March

Stage of Keratinocyte Differentiation Is a Key Determinant of Viral Susceptibility in Human Skin

JAK Signaling Is Critically Important in Cytokine-Induced Viral Susceptibility of Keratinocytes

Abrocitinib effect on patient‐reported outcomes in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension JADE EXTEND study

Abrocitinib efficacy and safety in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension JADE EXTEND study

Upadacitinib treatment withdrawal and retreatment in patients with moderate‐to‐severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial

S. aureus virulence factors decrease epithelial barrier function and increase susceptibility to viral infection

Bleach baths enhance skin barrier, reduce itch but do not normalize skin dysbiosis in atopic dermatitis

Supply Chain Disruptions during COVID-19 Pandemic Uncover Differences in Keratinocyte Culture Media

Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis

Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper

Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study

Collaborators (14)

Nicolette W. de Jong

Kate Grimshaw

Kirsi Jarvinen

Mette Søndergaard Deleuran

Matthew Brewer

E. L. Simpson

Masayuki Amagai

Michael Makris

Anna De Benedetto

Kenji Kabashima

S.R. Gill

Juilee Thakar

Bruce Strober

H. Mark Kenney

Make your next move.